A phase II trial of tideglusib in Alzheimer's disease.
Lovestone S, Boada M, Dubois B, Hüll M, Rinne JO, Huppertz HJ, Calero M, Andrés MV, Gómez-Carrillo B, León T, del Ser T; ARGO investigators.
Lovestone S, et al. Among authors: leon t.
J Alzheimers Dis. 2015;45(1):75-88. doi: 10.3233/JAD-141959.
J Alzheimers Dis. 2015.
PMID: 25537011
Clinical Trial.